Management of Controversial Gastroenteropancreatic (GEP) Neuroendocrine Tumour (NET) Clinical Situations (CS) with Somatostatin Analogues (SSAs): Results of a Delphi Questionnaire (Q) Panel from the NETPraxis Program

#1343

Introduction: In NET CS where use of SSAs is controversial due to lack of evidence, clinical experience and expert opinion can help establish recommendations.

Aim(s): The NETPraxis program aims to develop a common guidance for controversial CS with SSAs in clinical practice in Spain.

Materials and methods: 5 CS were defined with a common core (non-functioning NET, not susceptible of surgery/locoregional therapy, Ki672/3 of responses in the same tertile).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Sevilla I

Authors: Sevilla I, Segura A, Capdevila J, Lopez C, Garcia Carbonero R,

Keywords: SSA, Delphi, NETPraxis,